7,625.48

+45.41

+0.60%

52,282.48

+512.17

+0.99%

25,643.71

+206.71

+0.81%

2,829.29

+17.45

+0.62%

4.8900

-0.0390

-0.79%

18.97

-0.45

-2.32%

3,971.80

+72.90

+1.87%

77,786.33

-138.33

-0.18%

Crude Oil Dec 26

97.27

-6.85

-6.58%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Nasdaq Real Time Price USD

Aspire-Lakewood Holdings, Inc. (ASBP)

7.99 -0.12 (-1.48%)

As of 9:44:08 AM EST. Market Open.

Loading Chart for ASBP

Chart Range Bar

Interval:

In partnership with ChartIQ

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.

EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal

EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal

OTC Markets Life Sciences Investor Forum: Stephen Quesenberry, General Counsel and Director of Product Development, of Aspire Biopharma with Zacks SCR’s David Bautz, PhD

OTC Markets Life Sciences Investor Forum: Stephen Quesenberry, General Counsel and Director of Product Development, of Aspire Biopharma with Zacks SCR’s David Bautz, PhD

Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th

Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th

ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier?

ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier?

Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

Aspire Biopharma Issues Shareholder Letter

Aspire Biopharma Issues Shareholder Letter

Aspire Biopharma (ASBP) Authorizes $5M Share Repurchase Program

Aspire Biopharma (ASBP) Authorizes $5M Share Repurchase Program

Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program

Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program

Aspire Biopharma Acquires Automotive Supplier Dura Driver Control Systems in $30M Deal (ASBP)

Aspire Biopharma Acquires Automotive Supplier Dura Driver Control Systems in $30M Deal (ASBP)

Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members

Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members

Mobilize your Website

View Site in Mobile | Classic

Share by: